Quick Sequential Organ Failure Assessment As a Prognostic Factor for Infected Patients Outside the Intensive Care Unit: a Systematic Review and Meta-analysis
Overview
General Medicine
Affiliations
Quick Sequential Organ Failure Assessment (qSOFA) was proposed to replace SIRS as a new screening tool for the identification of septic patients at high mortality. However, researches from infected patients outside of ICU especially in Emergency Department (ED) drew contradictory conclusions on the prognostic value of qSOFA. This systematic review evaluated qSOFA as a prognostic marker of infected patients outside of ICU. The primary outcome was hospital mortality or 28- or 30-day mortality. Data were pooled based on sensitivity and specificity. Twenty-four trials with 121,237 participants were included. qSOFA had a poor sensitivity (0.58 [95% CI 0.47-0.67], 0.54 [95% CI 0.43-0.65]) and moderate specificity (0.69 [95% CI 0.48-0.84], 0.77 [95% CI 0.66-0.86]) for prediction of mortality in patients outside of ICU and ED patients only. Studies that used in-hospital mortality showed a higher sensitivity (0.61 [95% CI 0.50-0.71] vs 0.32 [95% CI 0.15-0.49]) and lower specificity (0.70 [95% CI 0.59-0.82] vs 0.92 [95% CI 0.85-0.99]) than studies that used 28 or 30-day mortality. Studies with overall mortality < 10% showed higher specificity (0.89 [95% CI 0.82-0.95] vs 0.62 [95% CI 0.48-0.76]) than studies with overall mortality ≥ 10%. There is no difference in the accuracy of diagnosis of sepsis between positive qSOFA scores and SIRS criteria. qSOFA was poor sensitivity and moderate specificity in predicting mortality of infected patients outside of ICU especially in ED. Combining qSOFA and SIRS may be helpful in predicting mortality.
Mesenchymal stem cells from different sources for sepsis treatment: prospects and limitations.
Chen H, Ling X, Zhao B, Chen J, Sun X, Yang J Braz J Med Biol Res. 2024; 57:e13457.
PMID: 39417448 PMC: 11484354. DOI: 10.1590/1414-431X2024e13457.
De Silva M, Chadwick W, Naidoo N Scand J Trauma Resusc Emerg Med. 2023; 31(1):74.
PMID: 37946312 PMC: 10634129. DOI: 10.1186/s13049-023-01111-y.
Validation of the qSOFA and CRB-65 in SARS-CoV-2-infected community-acquired pneumonia.
Richter T, Tesch F, Schmitt J, Koschel D, Kolditz M ERJ Open Res. 2023; 9(3).
PMID: 37337510 PMC: 10105511. DOI: 10.1183/23120541.00168-2023.
Application Prospect of the SOFA Score and Related Modification Research Progress in Sepsis.
Wang X, Guo Z, Chai Y, Wang Z, Liao H, Wang Z J Clin Med. 2023; 12(10).
PMID: 37240599 PMC: 10218823. DOI: 10.3390/jcm12103493.
Liu Y, Li D, Jia Y, Yu J, Li F, Gao Y Inquiry. 2023; 60:469580231163089.
PMID: 37070701 PMC: 10123918. DOI: 10.1177/00469580231163089.